Your browser doesn't support javascript.
loading
Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations.
Bartziokas, Konstantinos; Papathanasiou, Evgenia; Papaioannou, Andriana I; Papanikolaou, Ilias; Antonakis, Emmanouil; Makou, Ioanna; Hillas, Georgios; Karampitsakos, Theodoros; Papaioannou, Ourania; Dimakou, Katerina; Apollonatou, Vasiliki; Verykokou, Galateia; Papiris, Spyros; Bakakos, Petros; Loukides, Stelios; Kostikas, Konstantinos.
Afiliação
  • Bartziokas K; Respiratory Medicine Department, University of Ioannina, 45110 Ioannina, Greece.
  • Papathanasiou E; 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens, 10679 Athens, Greece.
  • Papaioannou AI; 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens, 10679 Athens, Greece.
  • Papanikolaou I; 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens, 10679 Athens, Greece.
  • Antonakis E; Respiratory Medicine Department, Corfu General Hospital, 49100 Corfu, Greece.
  • Makou I; Respiratory Medicine Department, Corfu General Hospital, 49100 Corfu, Greece.
  • Hillas G; Respiratory Medicine Department, Corfu General Hospital, 49100 Corfu, Greece.
  • Karampitsakos T; 5th Respiratory Medicine Department, Sotiria Chest Hospital, 11527 Athens, Greece.
  • Papaioannou O; 5th Respiratory Medicine Department, Sotiria Chest Hospital, 11527 Athens, Greece.
  • Dimakou K; 5th Respiratory Medicine Department, Sotiria Chest Hospital, 11527 Athens, Greece.
  • Apollonatou V; 5th Respiratory Medicine Department, Sotiria Chest Hospital, 11527 Athens, Greece.
  • Verykokou G; 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens, 10679 Athens, Greece.
  • Papiris S; 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens, 10679 Athens, Greece.
  • Bakakos P; 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens, 10679 Athens, Greece.
  • Loukides S; 1st Respiratory Medicine Department, National and Kapodistrian University of Athens, 10676 Athens, Greece.
  • Kostikas K; 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens, 10679 Athens, Greece.
J Pers Med ; 13(4)2023 Apr 19.
Article em En | MEDLINE | ID: mdl-37109072
BACKGROUND: In recent years, blood eosinophils have been evaluated as a surrogate biomarker for eosinophilic airway inflammation and as a prognostic indicator of the outcomes of hospitalized COPD subjects. During an exacerbation of COPD, eosinopenia has been proposed as a prognostic marker of adverse outcomes. OBJECTIVES: The aim of the present post hoc analysis was to elucidate the effectiveness of blood eosinophils for predicting the need of NIV in subjects with COPD exacerbation. METHODS: Consecutive subjects admitted to a hospital for COPD exacerbation were included in the analysis. The eosinophil count from the first complete blood count was used to designate the eosinophil groups. The relationship between the clinical characteristics and blood eosinophil counts, as dichotomized using 150 cells/µL, was evaluated. Results Subjects with blood eosinophil number < 150 k/µL had a more severe disease on admission compared to subjects with ≥150 k/µL, regarding pH 7.400 (7.36, 7.44) vs. 7.42 (7.38, 7.45), p = 0.008, PO2/FiO2 levels 238.1 (189.8, 278.6) vs. 276.2 (238.2, 305.6), p < 0.001, CRP (mg/L) levels 7.3 (3.1, 19.9) vs. 3.5 (0.7, 7.8), p < 0.001 and required a longer hospital stay (days) 10.0 (8.0, 14.0) vs. 5.0 (3.0, 7.0) p < 0.001 respectively. The number of blood eosinophils correlated with the levels of CRP upon admission (p < 0.001, r = -0.334), with arterial pH upon admission (p < 0.030, r = 0.121), with PO2/FiO2 (p < 0.001, r = -0.248), and with duration of hospital stay (p < 0.001, r = -0.589). In the multinomial logistic regression analysis, blood eosinophil count < 150 k/µL was an independent predictor of the use of NIV during hospital stay. CONCLUSION: During COPD exacerbation, low blood eosinophil levels upon admission are related to more severe disease and can be used as a predictor of the need of NIV. Further prospective studies are needed to identify the use of blood eosinophil levels as a predictor of unfavorable outcomes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pers Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pers Med Ano de publicação: 2023 Tipo de documento: Article